Test of Aquatic Mobility of SMA Infants (BAINSMA)

November 18, 2025 updated by: Assistance Publique - Hôpitaux de Paris

Analysis of Mobility in the Bath for Infants Affected With Spinal Muscular Atrophy

Spinal muscular atrophy (SMA) is a genetic neurodegenerative disease impacting spinal cord motor neurons, leading to motor and respiratory issues and, ultimately, death. With emerging therapies, a need arises to enhance motor function assessment in severely hypotonic infants (SMA type 1) as traditional scales on examination tables lack completeness due to gravity's influence.

The study team has developed a "bath test" to observe infants' motor skills in water, eliminating gravity's effects. This test aims to detect subtle movements using inertial sensors, potentially revealing more active motor neurons in aquatic conditions. It aids in identifying infants with motor improvement potential, even if they show limited mobility outside water, and tracks disease progression and therapy responses.

Presently, pediatric neurologists in France use parent-provided bathing videos for evaluations, but these lack standardization and precision. The study aims to establish a standardized evaluation protocol with quantifiable data.

The study's key objective is to evaluate severely hypotonic SMA infants using inertial sensors, including accelerometers, gyrometers, and magnetometers. The study will conduct "dry" and "water" assessments using a specially designed bathtub. This method's goal is to quantify water-based movements accurately.

Simultaneously, the study seeks to establish semi-quantitative evaluation criteria to create a clinical assessment scale for infant motor function in bathtubs. This scale will aid doctors in therapeutic decisions. The study will not influence the treatment or therapeutic decisions made for the children being tested.

Collected data from "dry" and "water" conditions will be statistically analyzed and compared to reference motor assessment scales (e.g., CHOP INTEND and HINE) and electromyography (CMAP-EMG) results, commonly used in diagnosis and monitoring. Blurred video recordings will assist in protocol monitoring and sensor data analysis.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

This is a multicenter research project coordinated by the Child Neuromuscular Unit at Raymond Poincaré Hospital. Additionally, two other pediatric neurology departments, part of the national neuromuscular network FILNEMUS (https://www.filnemus.fr/), will participate in the study: Necker Children's Hospital and Armand Trousseau Hospital.

The study's population will include all infants diagnosed with spinal muscular atrophy (SMA), specifically SMA type 1, who have onset before 6 months of age and have been evaluated by the French Therapeutic Commission. Participation in the study will be contingent on parental or guardian consent during follow-up visits.

Spinal muscular atrophy is a genetic neurodegenerative condition that affects spinal motor neurons, causing motor and respiratory paralysis and ultimately leading to death. As groundbreaking therapies emerge, there's an increasing need to refine the methods used to assess motor function, especially in infants with severe hypotonia due to SMA type 1. Traditional reference scales used on examination tables are limited in their accuracy because of gravitational effects. Consequently, there's growing interest in evaluating these children's motor skills in water to detect movements unburdened by gravity. Pediatric neurologists in France (SFNP) have already acknowledged the potential value of parental video recordings during infant baths. However, the lack of standardization in recording conditions, coupled with the subjective nature of video interpretations, underscores the necessity for a more standardized and quantifiable approach. Herein lies the application of our proposed evaluation utilizing inertial sensors.

Utilizing inertial sensors to detect subtle movements can highlight still-active yet minimally functional motor neurons. Such detection can be pivotal in identifying children who, despite severe motor skill limitations in traditional settings, still possess developmental potential. Our study seeks to leverage these sensors-equipped with accelerometers, gyroscopes, and magnetometers-to carry out evaluations both in ''dry'' conditions and ''water'' conditions, using a specially designed, secure bathtub.

The study aims to validate the relevance of quantifying movements in aquatic settings using inertial sensors, in order to assess motor function in very hypotonic children. Additionally, this study will contribute to the development of a semi-quantitative clinical evaluation grid for assessing infant motor function in water, assisting physicians in making more informed therapeutic decisions for these children. Data obtained from measurements with inertial sensors in both environments ("dry" and "water") will be correlated with scores from validated motor scales (CHOP INTEND; HINE-2) and the clinical characteristics of the patients (e.g., age, disease duration, SMA type, SMN2 copies, severity, CMAPs [EMG]). Anamnestic, clinical and inertial data will be anonymized.

The equipment required for the protocol comprises an examination table, a bath, a support for the head and back (https://www.neut.fr/fr/), 8 CE-validated Xsens DOT© inertial sensors, a dedicated research smartphone with the Xsens DOT© application for data export, a camera mounted on a pole connected to an acquisition tablet. The study will utilize a fixed PC computer with secure access, located in a dedicated research room within the Pediatric Neurology and Intensive Care Unit at Raymond Poincaré Hospital.

Video recording throughout the evaluation will be carried out from an overhead perspective, capturing all four limbs in the frame and ensuring that the child occupies approximately 50% of the camera's field of vision. To comply with privacy regulations (MR-001), the videos will obscure any identifying features, such as faces or other body parts of the patients. These videos will serve as a reference for controlling and validating the data collected by the inertial sensors.

The study's outputs will include inertial data from 8 inertial sensors placed on the arms (2), forearms (2), thighs (2), and legs (2). Our motor evaluation process is split into two distinct phases, totaling 6 minutes: a "dry" phase affected by gravity, and a "water" phase where gravity's effects are mitigated. The surrounding time is allocated for essential tasks such as positioning the child, fitting the sensors, and ensuring the infant's comfort throughout the process. Notably, our study doesn't seek to alter the standard care or therapeutic decisions for the participants.

The measurements will follow a specific process:

  • "Dry" phase: This involves evaluating limb movements under the constraints of gravity. The child is placed in a supine position on the examination table set horizontally (0°). To minimize signal artifacts, physical contact with the child should be avoided. If the child's behavior is unfavorable (e.g., crying), the measurement is paused and resumed once the child's condition stabilizes. Spontaneous or induced movements are collected for 2 minutes, with the entire duration filmed for monitoring the inertial sensor data.
  • Intermediate phase: The diaper is removed, and the child is positioned in a support inclined at 20°, then transferred to the bathtub. This transition should be made in a reassuring manner for the child, respecting their pace of adaptation.
  • "Water" phase: This phase involves evaluating limb movements without gravity constraints. Spontaneous or induced movements are collected for 4 minutes, with the entire duration filmed for monitoring the inertial sensor data. Measurements may also be paused and resumed based on the child's behavior.

The processes of sensor installation and sensor removal are accompanied by sensorimotor stimulation.

Study Type

Interventional

Enrollment (Estimated)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • France
      • Garches, France, 92380
        • Recruiting
        • Infantile neuromuscular unity - Department of paediatric neurological care and intentive care unity, Raymond Poincaré Hospital - APHP
        • Contact:
        • Contact:
          • Marta Gomez Garcia de la Banda, MD
        • Principal Investigator:
          • Marta Gomez Garcia de la Banda, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Infants with muscle weakness (commonly referred to as floppy babies):

    • Confirmed diagnosis of SMA through gene mutation or deletion (SMN1 gene).
    • Receiving standard care.
    • Age less than 12 years and a height of less than 90 cm at the time of inclusion.
  • Patients enrolled in a social security scheme.
  • Informed consent signed by both parents of the child and the investigator.

Exclusion Criteria:

  • Patients presenting with lesions in the spinal cord or conditions affecting the cardiorespiratory system.
  • Patients covered under the French Aid in Health for Foreign People program (AME).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mobility Assessment
This study involves a single arm, without a comparator group. The comparison will be made between the data for movements in conditions outside the water and inside the water.
Other: Mobility study in dry conditions
Record the movements of the baby's extremities using inertial sensors while the baby moves outside of the water.
Other: Mobility study in water conditions
Record the movements of the baby's extremities using inertial sensors while the baby moves inside the water.
Other Names:
  • Garches Bath Test (GBT)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Delta of 95th percentile of free acceleration norm (in m/s²)
Time Frame: through study completion, an average of 15 months
Difference of free acceleration norm (in m/s²) for each measurement point respectively (elbows; wrists; knees; ankles), between "dry" and "water" condition.
through study completion, an average of 15 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Assistance Publique - Hôpitaux de Paris

Investigators

  • Principal Investigator: Susana Quijano-Roy, MD, PhD, Paediatric neurological and intentive care unity, Raymond Poincaré Hospital - APHP
  • Study Director: Nour Maalouf, Psychomotor Therapist DE, Paediatric neurological and intentive care unity, Raymond Poincaré Hospital - APHP

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 26, 2025

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Study Registration Dates

First Submitted

October 30, 2023

First Submitted That Met QC Criteria

November 21, 2023

First Posted (Actual)

November 30, 2023

Study Record Updates

Last Update Posted (Actual)

November 21, 2025

Last Update Submitted That Met QC Criteria

November 18, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • APHP231293
  • 2022-A01419-34 (Registry Identifier: IDRCB)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infantile Spinal Muscular Atrophy

Clinical Trials on Mobility study in dry conditions

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe